A team of UC Davis Health researchers has shown that CD34 + stem cells can be safely administered into retinitis pigmentosa (RP) patients' eyes and may offer therapeutic benefits. The phase 1 ...
“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII expression, with factor VIII activity correlating to vector copy number in ...
5d
GlobalData on MSNElixirgen’s gene therapy shows promise in telomere biology disordersEarly results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...
Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation. Leukemia. 2025;1-11.
Pain and clinical scores were calculated for each patient. Image analysis to calculate area percent for TLR-2 and CD34 immuno-expression was performed. Data was tabulated and statistically analyzed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results